{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:57:45Z","timestamp":1768561065621,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00610-7","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T02:37:56Z","timestamp":1749177476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating computational and experimental approaches in early-stage Alzheimer\u2019s drug discovery: a systematic review"],"prefix":"10.1007","volume":"39","author":[{"given":"Mahir","family":"Azmal","sequence":"first","affiliation":[]},{"given":"Jibon Kumar","family":"Paul","sequence":"additional","affiliation":[]},{"given":"Md. Naimul Haque","family":"Shohan","sequence":"additional","affiliation":[]},{"given":"A. N. M. Shah Newaz Been","family":"Haque","sequence":"additional","affiliation":[]},{"given":"Mohua","family":"Mrinmoy","sequence":"additional","affiliation":[]},{"given":"Omar Faruk","family":"Talukder","sequence":"additional","affiliation":[]},{"given":"Ajit","family":"Ghosh","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"610_CR1","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, John CM, Goate A (2011) Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med 3:77sr1. https:\/\/doi.org\/10.1126\/scitranslmed.3002369","journal-title":"Sci Transl Med"},{"key":"610_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M (2019) Clinical aspects of alzheimer\u2019s disease. Clin Biochem 72:3\u20136. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.04.015","journal-title":"Clin Biochem"},{"key":"610_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"P-P Liu","year":"2019","unstructured":"Liu P-P, Xie Y, Meng X-Y, Kang J-S (2019) History and progress of hypotheses and clinical trials for alzheimer\u2019s disease. Sig Transduct Target Ther 4:1\u201322. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Sig Transduct Target Ther"},{"key":"610_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH (2017) Amyloid Beta and phosphorylated Tau accumulations cause abnormalities at synapses of alzheimer\u2019s disease neurons. J Alzheimers Dis 57:975\u2013999. https:\/\/doi.org\/10.3233\/JAD-160612","journal-title":"J Alzheimers Dis"},{"key":"610_CR5","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M et al (2021) Interaction between A\u03b2 and Tau in the pathogenesis of alzheimer\u2019s disease. Int J Biol Sci 17:2181\u20132192. https:\/\/doi.org\/10.7150\/ijbs.57078","journal-title":"Int J Biol Sci"},{"key":"610_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for alzheimer disease. Nat Rev Neurol 14:399\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol"},{"key":"610_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nrd2959","volume":"8","author":"KR Brunden","year":"2009","unstructured":"Brunden KR, Trojanowski JQ, Lee VM-Y (2009) Advances in Tau-focused drug discovery for alzheimer\u2019s disease and related tauopathies. Nat Rev Drug Discov 8:783\u2013793. https:\/\/doi.org\/10.1038\/nrd2959","journal-title":"Nat Rev Drug Discov"},{"key":"610_CR8","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/biom13111613","volume":"13","author":"D Iqbal","year":"2023","unstructured":"Iqbal D, Alsaweed M, Jamal QMS et al (2023) Pharmacophore-Based screening, molecular docking, and dynamic simulation of fungal metabolites as inhibitors of Multi-Targets in neurodegenerative disorders. Biomolecules 13:1613. https:\/\/doi.org\/10.3390\/biom13111613","journal-title":"Biomolecules"},{"key":"610_CR9","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2174\/1568026623666221026091010","volume":"22","author":"SK Singh","year":"2022","unstructured":"Singh SK, Kumar A, Singh RB et al (2022) Recent applications of bioinformatics in target identification and drug discovery for alzheimer\u2019s disease. Curr Top Med Chem 22:2153\u20132175. https:\/\/doi.org\/10.2174\/1568026623666221026091010","journal-title":"Curr Top Med Chem"},{"key":"610_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/ph12010041","volume":"12","author":"MA Maia","year":"2019","unstructured":"Maia MA, Sousa E (2019) BACE-1 and \u03b3-secretase as therapeutic targets for alzheimer\u2019s disease. Pharmaceuticals 12:41","journal-title":"Pharmaceuticals"},{"key":"610_CR11","first-page":"1479","volume":"10","author":"E Tamagno","year":"2021","unstructured":"Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M (2021) Oxidative stress and beta amyloid in alzheimer\u2019s disease. Which Comes First: Chick or Egg?? Antioxid 10:1479","journal-title":"Which Comes First: Chick or Egg?? Antioxid"},{"key":"610_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijbiomac.2017.01.076","volume":"97","author":"B ul Islam","year":"2017","unstructured":"ul Islam B, Tabrez S (2017) Management of alzheimer\u2019s disease\u2014An insight of the enzymatic and other novel potential targets. Int J Biol Macromol 97:700\u2013709","journal-title":"Int J Biol Macromol"},{"key":"610_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/ddc3010009","volume":"3","author":"R Dhudum","year":"2024","unstructured":"Dhudum R, Ganeshpurkar A, Pawar A (2024) Revolutionizing drug discovery: A comprehensive review of AI applications. Drugs Drug Candidates 3:148\u2013171. https:\/\/doi.org\/10.3390\/ddc3010009","journal-title":"Drugs Drug Candidates"},{"key":"610_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20:200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"610_CR15","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"610_CR16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2174\/092986710791111206","volume":"17","author":"V Tumiatti","year":"2010","unstructured":"Tumiatti V, Minarini A, Bolognesi ML et al (2010) Tacrine derivatives and alzheimer\u2019s disease. Curr Med Chem 17:1825\u20131838. https:\/\/doi.org\/10.2174\/092986710791111206","journal-title":"Curr Med Chem"},{"key":"610_CR17","doi-asserted-by":"publisher","first-page":"e42479","DOI":"10.1016\/j.heliyon.2025.e42479","volume":"11","author":"H Nour","year":"2025","unstructured":"Nour H, Abchir O, Mounadi N et al (2025) Exploration of natural products for the development of promising cholinesterase inhibitors in alzheimer\u2019s disease treatment. Heliyon 11:e42479. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42479","journal-title":"Heliyon"},{"key":"610_CR18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/jccs.202200195","volume":"69","author":"H Nour","year":"2022","unstructured":"Nour H, Abdou A, Belaidi S et al (2022) Discovery of promising cholinesterase inhibitors for alzheimer\u2019s disease treatment through DFT, docking, and molecular dynamics studies of Eugenol derivatives. J Chin Chem Soc 69:1534\u20131551. https:\/\/doi.org\/10.1002\/jccs.202200195","journal-title":"J Chin Chem Soc"},{"key":"610_CR19","doi-asserted-by":"publisher","first-page":"e1900370","DOI":"10.1002\/cbdv.201900370","volume":"16","author":"M Asadi","year":"2019","unstructured":"Asadi M, Ebrahimi M, Mohammadi-Khanaposhtani M et al (2019) Design, synthesis, molecular docking, and cholinesterase inhibitory potential of Phthalimide-Dithiocarbamate hybrids as new agents for treatment of alzheimer\u2019s disease. Chem Biodivers 16:e1900370. https:\/\/doi.org\/10.1002\/cbdv.201900370","journal-title":"Chem Biodivers"},{"key":"610_CR20","doi-asserted-by":"publisher","unstructured":"Singh N, Vayer P, Tanwar S et al (2023) Drug discovery and development: introduction to the general public and patient groups. Front Drug Discov 3. https:\/\/doi.org\/10.3389\/fddsv.2023.1201419","DOI":"10.3389\/fddsv.2023.1201419"},{"key":"610_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","volume":"171","author":"IM Kapetanovic","year":"2008","unstructured":"Kapetanovic IM (2008) Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chemico-Biol Interact 171:165\u2013176. https:\/\/doi.org\/10.1016\/j.cbi.2006.12.006","journal-title":"Chemico-Biol Interact"},{"key":"610_CR22","doi-asserted-by":"publisher","first-page":"108371","DOI":"10.1016\/j.compbiolchem.2025.108371","volume":"116","author":"N Kaur","year":"2025","unstructured":"Kaur N, Gupta S, Pal J et al (2025) Design of BBB permeable BACE-1 inhibitor as potential drug candidate for alzheimer disease: 2D-QSAR, molecular docking, ADMET, molecular dynamics, MMGBSA. Comput Biol Chem 116:108371. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108371","journal-title":"Comput Biol Chem"},{"key":"610_CR23","doi-asserted-by":"publisher","unstructured":"Nour H, Yamari I, Abchir O et al Exploring Cannabis sativa L for anti-Alzheimer potential: an extensive computational study including molecular docking, molecular dynamics, and ADMET assessments. Med Chem 21:367\u2013384. https:\/\/doi.org\/10.2174\/0115734064318657240822064240","DOI":"10.2174\/0115734064318657240822064240"},{"key":"610_CR24","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1039\/c9md00337a","volume":"10","author":"L Blaikie","year":"2019","unstructured":"Blaikie L, Kay G, Kong Thoo Lin P (2019) Current and emerging therapeutic targets of alzheimer\u2019s disease for the design of multi-target directed ligands. Medchemcomm 10:2052\u20132072. https:\/\/doi.org\/10.1039\/c9md00337a","journal-title":"Medchemcomm"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00610-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:55:48Z","timestamp":1762451748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00610-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00610-7","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}